传统医疗系统开发通常需经历需求分析、编码、测试等多环节，耗时数天甚至数周。而本次实践彻底改变了这一模式。工作人员只需通过自然语言描述需 求，平台即可基于口语化指令自动生成系统框架，并完成从数据库设计到前端界面的全流程开发。最终，一个功能完整、交互流畅的预约挂号系统在20分 钟内成功部署，效率较传统模式提升20至50倍。 （AI智能开发界面） 这一突破性实践，正是落实龙华区二届五次党代会提出的"走在前、作示范、挑大梁，我们要全面迈向数智化发展，以数智龙华构筑升级路径"要求，在医 疗健康这一关键民生领域取得的先行成果，充分彰显全力推进"数智龙华"建设的决心与行动力。 近日，在深圳市卫生健康委的推动下，深圳市健研数管中心与深圳智谱华章公司联合研发出全球首个超大城市全域医疗智能编程赋能平台——"医疗AI编 程智能平台"及适配鸿蒙生态的"医鸿AI编程智能体"，并已部署至全市卫生专网，向所有医疗单位开放使用。这一创新平台打造出可在医院内网环境中实 现全程"零代码"的医疗系统开发环境，标志着医疗信息化正式进入"智能编程时代"。 2月6日上午，深圳市龙华区中心医院率先接入医疗AI编程智能平台，并首次通过自然语言与AI交互，仅 ...

创业慧康（300451.SZ）2月27日在投资者互动平台表示，公司与华检医疗在客户群体与决策链上高度重 合，双方协同以资源共享与路径复用为重点，将有效提升运营效率。协同合作不仅限于市场前端，未来 将通过业务贯通、数智决策、流通赋能的三级释放路径，打破数据壁垒，为医疗卫生机构提供更高效、 精准、可持续的医疗解决方案。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：董秘您好，华检医疗成为公司控股股东后，双方在医 疗信息化与体外诊断（IVD）领域的协同战略具体如何规划？新股东将在哪些方面为公司导入资源、资 金或客户，以帮助公司扭转当前的亏损局面？ ...

从资金流向上来看，当日医疗信息化板块主力资金净流出7.64亿元，游资资金净流入4.65亿元，散户资 金净流入2.99亿元。医疗信息化板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月26日医疗信息化板块较上一交易日下跌0.26%，海南海药领跌。当日上证指数报收 于4146.63，下跌0.01%。深证成指报收于14503.79，上涨0.19%。医疗信息化板块个股涨跌见下表： ...

格隆汇2月24日丨创业慧康(300451.SZ)在互动平台表示，公司暂无探索太空互联网医院的计划。 ...

Core Viewpoint - The medical information technology sector experienced a decline of 0.91% on February 24, with Keda Guokuan leading the drop [1] Group 1: Market Performance - On the same day, the Shanghai Composite Index closed at 4117.41, up by 0.87% [1] - The Shenzhen Component Index closed at 14291.57, up by 1.36% [1] Group 2: Capital Flow - The medical information technology sector saw a net outflow of 1.896 billion yuan from main funds, while retail investors contributed a net inflow of 1.59 billion yuan [1] - There was a net inflow of 306 million yuan from speculative funds [1]

Core Viewpoint - Guoxin Health (000503) anticipates a net profit loss of 409 million yuan for 2025, primarily due to fair value changes in investment assets, while focusing on core business development in data elements and AI healthcare [1][2]. Financial Performance - For 2025, Guoxin Health expects total revenue of 351 million yuan, remaining stable compared to the previous year; the net profit attributable to shareholders is projected to be -409 million yuan, mainly due to a loss of approximately 260 million yuan from the fair value changes of trading financial assets (Shenzhou Medical Technology) [2]. - The net profit after excluding non-recurring gains and losses is expected to be -148 million yuan, indicating stable performance in core business [2]. Company Status - On February 6, 2026, the company held its 12th board meeting to review a proposal regarding the management of temporarily idle raised funds, with further announcements expected regarding the implementation of this proposal [3]. Industry Policy and Environment - The medical information industry faced overall pressure in 2025, with over half of the companies in the sector forecasting negative net profits excluding non-recurring items. Guoxin Health emphasized its commitment to advancing health big data applications in medical insurance management and quality, aligning with the "Healthy China" and "Three Medical Collaborations" strategies [4]. Stock Performance - As of February 9, 2026, Guoxin Health's stock price is 9.46 yuan per share, with a total market capitalization of 9.264 billion yuan. The stock has increased by 6.53% year-to-date but has decreased by 18.52% over the past 20 days. The net outflow of main funds on that day was 291,700 yuan [5].

从资金流向上来看，当日医疗信息化板块主力资金净流出16.85亿元，游资资金净流入6.82亿元，散户资 金净流入10.04亿元。医疗信息化板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月13日医疗信息化板块较上一交易日下跌0.99%，东方国信领跌。当日上证指数报收 于4082.07，下跌1.26%。深证成指报收于14100.19，下跌1.28%。医疗信息化板块个股涨跌见下表： ...

经济观察网 健麾信息近期完成对博科国信38%股权的收购，实现对后者的控股，并披露其募投项目延 期至2027年2月。 经济观察网 健麾信息近期完成对博科国信38%股权的收购，实现对后者的控股，并披露其募投项目延 期至2027年2月。 公司项目推进 2026年2月5日，公司公告拟以7371.02万元收购博科国信（武汉）科技有限公司38%股权，交易完成后 持股比例从32%提升至70%，标的公司将成为控股子公司并纳入合并报表。本次收购基于标的公司2025 年度净利润1433万元，按13.54倍市盈率定价，并设置了2026年至2028年的业绩承诺条款，旨在整合医 疗信息化能力，加速海外市场拓展和"软硬件+AI"业务协同。 项目进展 公司项目推进 2026年2月5日，公司公告拟以7371.02万元收购博科国信（武汉）科技有限公司38%股权，交易完成后 持股比例从32%提升至70%，标的公司将成为控股子公司并纳入合并报表。本次收购基于标的公司2025 年度净利润1433万元，按13.54倍市盈率定价，并设置了2026年至2028年的业绩承诺条款，旨在整合医 疗信息化能力，加速海外市场拓展和"软硬件+AI"业务协同。 项目进 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月12日医疗信息化板块较上一交易日上涨0.7%，东方国信领涨。当日上证指数报收于 4134.02，上涨0.05%。深证成指报收于14283.0，上涨0.86%。医疗信息化板块个股涨跌见下表： 从资金流向上来看，当日医疗信息化板块主力资金净流入9.73亿元，游资资金净流出5.64亿元，散户资 金净流出4.09亿元。医疗信息化板块个股资金流向见下表： ...

Group 1 - The A-share AI application concept stocks are experiencing a strong upward trend, with sectors like AI office, AI healthcare, and industrial AI showing synchronized growth, leading to a positive market sentiment [1] - Key stocks such as Liou Co., Wanxing Technology, Koyuan Wisdom, and Guangyun Technology are performing well, indicating a leading and coordinated market structure [1] - Increased capital allocation towards AI applications is driven by accelerated commercialization, expanding application scenarios, and favorable policies, resulting in a healthy price-volume relationship in the sector [1] Group 2 - Recent government policies are promoting the large-scale implementation of AI applications, elevating the AI industry to a core strategic level for fostering new productive forces [2] - The commercialization of AI applications is accelerating, with market demand on the rise, as evidenced by significant price adjustments in AI products, reflecting an increase in commercial value [2] - The AI application industry is seeing a broad expansion across various sectors, with major companies like Kingsoft Office and iFLYTEK reaching market capitalizations exceeding 100 billion [2] Group 3 - The AI office software sector is experiencing growth, with a reported 28% year-on-year increase in AI office software usage since early 2026, driving demand in the industry [3] - The AI healthcare market is projected to reach 38.5 billion yuan by 2025, with the proliferation of AI applications enhancing the development of medical information technology [3] - The industrial automation sector is benefiting from the integration of AI, with a 19% year-on-year increase in sales of AI inspection equipment since early 2026, indicating a positive trend in demand [3]